CISA warns of old vulnerabilities in Paessler PRTG servers - techzine.eu
2025-02-17 • Google News
Portage Biotech Inc (PRTG)
US$ 8.98-8.92%
Price Chart
Key Statistics
Market Cap
$ 12.98M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
228.04K
52W High
$ 15.82
52W Low
$ 2.10
Dividend Yield
0.00%
Beta
0.84
Technicals
50-Day MA
7.062
200-Day MA
5.3802
52 Week High
15.8181
52 Week Low
2.098
About PRTG
Portage Biotech Inc., a clinical stage immune-oncology company, engages in the research and develops pharmaceutical and biotechnology products.
Employees
7
Headquarters
Tortola, British Virgin Islands
CEO
Dr. Robert A. Kramer Ph.D.
Latest News
Hands on: I tested the Paessler PRTG Network Monitor - see what I thought of it - TechRadar
2025-03-17 • Google News
New Cancer Breakthrough: PORT-7 Outperforms Standard Treatment in Mesothelioma Study - Stock Titan
3 weeks ago • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg